Open original FDA record ↗Recall record
- FDA identifier
- Z-2596-2018
- Company in FDA record
- QIAGEN
- FDA record creation date
- Aug 2, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Underfilled reagent well that could lead to incorrect results
Source facts
- Action
- On May 28, 2018 QIAGEN issued an Urgent Notice of Product Field Action and a Acknowledgement of Receipt form to customers. Actions to be taken by the customer/user/commercial partner are as follows: - If you have any remaining stocks, do not use them, contact our technical service for a free-of-charge replacement and dispose of the product in accordance with your national, local safety and environmental regulations. - Review the notice with your laboratory/medical director. - Forward the information to all individuals and departments within your organization. - If product was further distributed, forward a copy of the notice to the product end user. - QIAGEN also recommends a review of the corresponding results. Consider the possibility of under-quantification and false negative results and evaluate the need for retesting with different EZ1 DSP Virus Kit lots e.g. depending on the clinical presentation and history of the patient - Complete and return the Acknowledgement of Receipt form and email to: quality.communications@qiagen.com.
- Initiated
- 2018-05-28
- Root cause
- Under Investigation by firm
- Terminated
- 2019-04-05
- Distribution
- Domestic - MD Internationally - AE, AU , CZ, DE, DZ, ES, FR, GB, HK , IE, IT, NO, RO & SA
- Recall number
- Z-2596-2018
- Recall status
- Terminated
- CDRH record ID
- 165432
- FDA record created
- 2018-08-02
- Recall event number
- 80430